3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
8
Leukemia, Lymphocytic, Chronic, B-Cell
7
Lymphoma, Mantle-Cell
6
Unspecified Adult Solid Tumor, Protocol Specific
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Lymphoma, Large B-Cell, Diffuse
5
Lymphoma, Follicular
5
Lymphoma, B-Cell, Marginal Zone
5
Colorectal Neoplasms
5
Waldenstrom Macroglobulinemia
4
Rectal Neoplasms
4
Pancreatic Neoplasms
4
Lymphoma, T-Cell, Cutaneous
4
Lymphoma, Non-Hodgkin
4
Lymphoma, Large-Cell, Immunoblastic
4
Lymphoma, Extranodal NK-T-Cell
4
Leukemia, Prolymphocytic
4
Hodgkin Disease
4
Carcinoma, Non-Small-Cell Lung
4
Carcinoma, Hepatocellular
4
Burkitt Lymphoma
4
Squamous Cell Carcinoma of Head and Neck
3
Sezary Syndrome
3
Neoplasms
3
Mycosis Fungoides
3
Multiple Myeloma
3
Lymphoma, Large-Cell, Anaplastic
3
Leukemia, Myeloid, Acute
3
Immunoblastic Lymphadenopathy
3
Interventions
Temozolomide
156
Bevacizumab
69
Radiotherapy
61
Magnetic Resonance Spectroscopy
59
Irinotecan
31
Surgical Procedures, Operative
23
Radiation
23
Carboplatin
23
Specimen Handling
20
Carmustine
20
Nivolumab
19
Biopsy
17
Lomustine
16
Aminolevulinic Acid
15
Radiotherapy, Intensity-Modulated
13
Cyclophosphamide
13
trametinib
12
pembrolizumab
12
Radiosurgery
12
Erlotinib Hydrochloride
12
fluorodopa F 18
11
Topotecan
11
Everolimus
11
Blood Specimen Collection
11
X-Rays
10
IL13-PE38
10
dabrafenib
9
Etoposide
9
ribociclib
8
poly ICLC
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Glioma
×
Pharmacogenomic Testing
×
Clear all
NCT01165333
2026-03-16
CILENT
Centre Oscar Lambret
Phase 1
Completed
32 enrolled